KALYDECO 50 mg, granulés en sachet — 56 sachet(s) (4x14) BoPET : polyéthylène téréphtalate biaxialement orienté polyéthylène aluminium
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400930040997 -
CIP7
3004099 -
CIS
66701315 -
Registration number
EU/1/12/782
What the source publishes
- Holder
- VERTEX PHARMACEUTICALS (EUROPE) LIMITED
- Active ingredients
- IVACAFTOR
- Form
- granulés
- Package
- 56 sachet(s) (4x14) BoPET : polyéthylène téréphtalate biaxialement orienté polyéthylène aluminium
- Routes
- orale
- Administrative status
- authorised
- Supply regime
- prescription initiale hospitalière semestrielle ; liste I ; renouvellement non restreint
- Marketing status
- Déclaration de commercialisation
- Authorised on
- 2015-11-16
- Prescription
- Prescription or restricted
Names this record is found by
- KALYDECO 50 mg, granulés en sachet — 56 sachet(s) (4x14) BoPET : polyéthylène téréphtalate biaxialement orienté polyéthylène aluminium
- KALYDECO 50 mg, granulés en sachet
- IVACAFTOR
Complete source data
{
"cis": "66701315",
"cip7": "3004099",
"form": "granulés",
"name": "KALYDECO 50 mg, granulés en sachet — 56 sachet(s) (4x14) BoPET : polyéthylène téréphtalate biaxialement orienté polyéthylène aluminium",
"cip13": "3400930040997",
"holder": "VERTEX PHARMACEUTICALS (EUROPE) LIMITED",
"routes": [
"orale"
],
"holders": [
"VERTEX PHARMACEUTICALS (EUROPE) LIMITED"
],
"currency": "EUR",
"marketed": true,
"bdmStatus": null,
"useDomain": "unknown",
"publicPrice": "9877.59",
"authorisedOn": "2015-11-16",
"compositions": [
{
"name": "IVACAFTOR",
"nature": "SA",
"strength": "50 mg",
"linkageNumber": "1",
"substanceCode": "91389",
"dosageReference": "un sachet",
"pharmaceuticalElement": "granulés"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "prescription initiale hospitalière semestrielle ; liste I ; renouvellement non restreint",
"dispensingFee": "1.02",
"medicinePrice": "9876.57",
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "KALYDECO 50 mg, granulés en sachet",
"marketingStatus": "Déclaration de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-01-08",
"CIS_CIP_bdpm": "2026-11-19",
"CIS_CPD_bdpm": "2026-01-08",
"CIS_COMPO_bdpm": "2026-01-08"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "oui",
"packageDescription": "56 sachet(s) (4x14) BoPET : polyéthylène téréphtalate biaxialement orienté polyéthylène aluminium",
"patientEligibility": "not-assessed",
"reimbursementRates": [
"65%"
],
"marketingDeclaredOn": "2017-03-17",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": false,
"administrativeStatus": "authorised",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"IVACAFTOR"
],
"authorisationProcedure": "Procédure centralisée",
"prescriptionConditions": [
"prescription initiale hospitalière semestrielle",
"liste I",
"renouvellement non restreint"
],
"reimbursementIndications": "Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans les cas suivants :<br><br>- Mucoviscidose (maladie génétique se traduisant en particulier par une production trop importante de mucus, et qui provoque une grave atteinte de certains organes comme les poumons ou le foie), chez des enfants de plus de 6 mois et pesant de 5 à 25 kg. ; JOURNAL OFFICIEL ; 20/11/20",
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": "EU/1/12/782",
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400930040997"